World’s first AI-developed drug for deadly lung disease enters landmark clinical trials in China, US
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Evidence that AI tools can slash years off early-stage analysis will ‘revolutionise drug discovery’, researchers say.